WITUJUNG
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
MFDS item code 201904197 · Approved 2019.06.17
This product's status changed to Expired on 2024.06.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (e.g., ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used for conditions related to excessive gastric acid, such as gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It is also effective in treating reflux esophagitis and ulcers that may occur post-surgery. It is administered pre-anesthesia to prevent Mendelson's syndrome and is also used for NSAID-induced ulcers. It helps alleviate symptoms by addressing various gastrointestinal diseases.
Usually, take 2 tablets orally twice daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to ulcers caused by nonsteroidal anti-inflammatory drugs and to concomitant therapy for preventing gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients undergoing dialysis treatment or those with kidney dysfunction. Patients who have had allergies to this drug or its components should also avoid it. Caution is advised for patients with a history of the rare condition acute porphyria as this medication may exacerbate symptoms. It is not recommended for patients who have undergone gastrointestinal surgery, pregnant women, women of childbearing potential, and premature or newborn infants. Patients on dietary restrictions limiting potassium intake should refrain from using this medication. Caution should be exercised in patients with liver dysfunction or a history of drug allergies, particularly in elderly individuals and those with a history of kidney issues. When taken in conjunction with NSAIDs, gastrointestinal status should be monitored regularly. This medication may mask symptoms of stomach cancer, so gastric ulcer patients or middle-aged patients with newly developed dyspepsia should confirm malignancy prior to treatment. If Helicobacter pylori is present, it is important to undergo treatment to eliminate the bacteria. Special care is needed for patients in intensive care units, those with low phosphate levels, or patients who have difficulty swallowing. Severe allergic reactions, such as anaphylactic shock, may occur infrequently during the use of this medication, so if symptoms appear, administration should be discontinued immediately, and treatment should be sought. Discontinue use if hypersensitivity reactions such as skin rash, urticaria, or difficulty breathing occur. Rare side effects may include a decrease in blood cell count, liver dysfunction, arrhythmia, gastrointestinal symptoms, dizziness, drowsiness, and confusion, and patients should consult a physician if any abnormal symptoms occur. Avoid long-term use and only take the minimum required dose, while closely monitoring treatment progress. Caution is necessary for elderly patients or those with chronic lung disease or diabetes, as the risk of pneumonia may increase. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so notify your physician of any other medications you are taking. Pregnant or breastfeeding women should refrain from using this medication. Safety and efficacy have not been established in children, so its use is not recommended. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary. This medication reduces gastric acid secretion and may promote bacterial proliferation in the gastrointestinal tract, so regular check-ups, including ophthalmologic assessments, may be required during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and ensure safe use.
Round white film-coated tablet
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.